References
1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–137
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, Mclaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204
3. Selhub J, Miller JW,:The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosyl methionine of the remethylation and transsufuration of homocysteine . Am J Clin Nutr 55:131-138,1992.
4. Bonnette RE, Caudill MA, Boddie AM, Hutson AD, Kauwell GP, Bailey LB (1998) Plasma homocyst(e)ine concentr-ations in pregnant and nonpregnant women with controlled folate intake. Obstet gynecol 92: 167-170
5. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. (1999) Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180: 660-664
6. De Bree A, Verschuren WM, Blom HJ, Kromhout D (2001) Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 154: 150-154
7. Herrmann W (2001) The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 39: 666-674
8. Singh Urmila,Gupta HP,Singh RK et al.Homocysteine: Association with preeclampsia and normotensive pregnancy.J Obstet Gynecol India Vol.59,No . 3:May/June 2009 pg 235-238
9. Rajkovic A, Catalano PM, Malinow MR (1997) Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 90: 168-171
10. The H Factor Solution: Homocysteine, the Best Single Indicator of Whether You Are Likely to Live Long or Die Young Authors: James Braly and Patrick Holford 2003 edition
11. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP (2001)Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104: 2569–2575
12. Yamamoto M, Hara H, Adachi T (2000) Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 486: 159–162
13. Wang G, Siow YL, O K (2000) Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 352: 817–826
14. Homocysteine Lowering Trialists’ Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomi-sed trials. British Medical Journal 316, 894-898.
15. Chambers JC, Ireland H, Thompson E, et al. MTHFR C677T mutation and CHD risk in UK Indian Asians. Arterioscler Thromb Vas Biol 2000; 20; 2448-52.
16. Isber S (2006) The role of poor nutritional status and hyperhomocysteinemia in complicated pregnancy in Syria.Dissertation for awarding the Degree of Theoritical Medicine .University of Sarland; Faculty of Medicine, Clinical chemistry and Laboratory Medicine / Central laboratory, Homburg.
17. Anand SS, Yusuf S, Vuksan V, et al. Difference in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk ethnic groups (SHARE). Indian Heart J 2000; 52:535-43.
18. Chambers JC, Obeid, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355:523-7.
19. Abraham R, Brocon MC, North WR, Mc Fadyen IR. Diets of Asian pregnant women in Harrow: iron and vitamins. Hum Nutr Appl Nutr 1987; 41:164-73.
20. Mathews JH, Wood JK. Megaloblastic anaemia in vegetarian Asians. Clin Lab Haematol 1984; 6:1-7.
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.209
